Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves

被引:10
作者
Hurley, J. C. [1 ,2 ,3 ,4 ]
机构
[1] Ballarat Hlth Serv, Div Internal Med, Ballarat, Vic 3353, Australia
[2] Univ Melbourne, Sch Rural Hlth, Shepparton, Vic, Australia
[3] Ballarat Hlth Serv, Infect Control Comm, Ballarat, Vic 3353, Australia
[4] St John God Hosp, Ballarat, Vic, Australia
关键词
AMEBOCYTE LYSATE TEST; TUMOR-NECROSIS-FACTOR; MONOCLONAL ANTIENDOTOXIN ANTIBODY; HUMAN SEPTIC SHOCK; LIMULUS TEST; FEBRILE PATIENTS; CARDIOVASCULAR DYSFUNCTION; ESCHERICHIA-COLI; PLASMA ENDOTOXIN; CANINE MODEL;
D O I
10.1007/s10096-009-0841-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The limulus assay for endotoxin has been studied as a method for the rapid identification of gram-negative (GN) bacteraemia. The chromogenic (C-limulus) version is 100-fold more sensitive to an internal endotoxin standard than the earlier gelation version (G-limulus). The objective of this analysis is to compare the concordance between GN bacteraemia and endotoxaemia as determined in clinical studies using either version of the limulus assay. The summary results for the diagnostic odds ratio (DOR), sensitivity and specificity were derived using a hierarchical summary receiver operating characteristic (HSROC) method of meta-analysis. Fifty-eight studies (25 G-limulus and 33 C-limulus) were included. Surprisingly, the mean DOR (4.9; 3-7.9 versus 10.7; 5.2-21.8) was inferior for studies using the C-limulus versus the original G-limulus version of the assay. Moreover, among studies limited to sepsis syndrome patients, the mean DOR remains poor at 4.2 (1.8-9.5). The proportion of GN bacteraemic patients for whom endotoxaemia is not detectable with either version of the limulus assay is > 20% among the 58 studies overall, but > 30% after the exclusion of studies with < 25 patients and > 20% among studies of patients with sepsis syndrome. These findings help to reconcile seemingly disparate study results.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 81 条
  • [1] Ahmed T, 2004, J ENDOTOXIN RES, V10, P223, DOI [10.1179/096805104225005823, 10.1177/09680519040100040401]
  • [2] *AM COLL CHEST PHY, 1992, CHEST, V101, P1658
  • [3] E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial
    Angus, DC
    Birmingham, MC
    Balk, RA
    Scannon, PJ
    Collins, D
    Kruse, JA
    Graham, DR
    Dedhia, HV
    Homann, S
    MacIntyre, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1723 - 1730
  • [4] [Anonymous], CRIT CARE MED
  • [5] ENDOTOXIN CONCENTRATION IN NEUTROPENIC PATIENTS WITH SUSPECTED GRAM-NEGATIVE SEPSIS - CORRELATION WITH CLINICAL OUTCOME AND DETERMINATION OF ANTIENDOTOXIN CORE ANTIBODIES DURING THERAPY WITH POLYCLONAL IMMUNOGLOBULIN-M-ENRICHED IMMUNOGLOBULINS
    BEHRE, G
    SCHEDEL, I
    NENTWIG, B
    WORMANN, B
    ESSINK, M
    HIDDEMANN, W
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) : 2139 - 2146
  • [6] Buller H R, 1985, Prog Clin Biol Res, V189, P405
  • [7] CIRCULATING ENDOTOXIN AND TUMOR-NECROSIS-FACTOR DURING PEDIATRIC CARDIAC-SURGERY
    CASEY, WF
    HAUSER, GJ
    HANNALLAH, RS
    MIDGLEY, FM
    KHAN, WN
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (08) : 1090 - 1096
  • [8] CLUMECK N, 1977, NOUV PRESSE MED, V6, P1451
  • [9] Cooperstock M, 1985, Prog Clin Biol Res, V189, P329
  • [10] ENDOTOXEMIA IN HUMAN SEPTIC SHOCK
    DANNER, RL
    ELIN, RJ
    HOSSEINI, JM
    WESLEY, RA
    REILLY, JM
    PARILLO, JE
    [J]. CHEST, 1991, 99 (01) : 169 - 175